Iwai N. Pex11␣ deficiency impairs peroxisome elongation and division and contributes to nonalcoholic fatty liver in mice.
OBESITY AND OBESITY-ASSOCIATED FATTY LIVER DISEASE (FLD) are becoming global health problems in adults as well as in children (3, 6) . In recent years, nonalcoholic causes of FLD have attracted considerable attention (24) . Nonalcoholic fatty liver disease (NAFLD) can begin as a simple overstorage of unmetabolized energy in hepatocytes of individuals whose caloric intake exceeds the energy combustion capability of peroxisome proliferator-activated receptor-␣ (PPAR␣)-mediated fatty acid oxidation systems (3, 6, 11) .
Peroxisomes are ubiquitous organelles bounded by a single membrane; mammalian peroxisomes have many important metabolic functions, including ␤-oxidation of very long-chain fatty acids (VLCFA), ␣-and ␤-oxidization of long branchedchain fatty acids, synthesis of cholesterol and ether lipids, and H 2 O 2 metabolism (18, 34, 35) . Peroxisomes are highly versatile and dynamic organelles whose size, shape, number, and protein content adapt to the cell type, metabolic requirements, and extracellular stimuli (17, 23, 28, 29, 35) . The mechanisms involved in peroxisome biogenesis have been clarified considerably. Currently, two different mechanisms are thought to be involved in peroxisome biogenesis. Compelling evidence has been presented to show that peroxisomes can form de novo from the endoplasmic reticulum (ER) via a maturation process (12, 13, (31) (32) (33) . Peroxisomes can also multiply through growth and division (4, 7, 17) . Peroxisome proliferation can be divided into at least three distinct steps in mammalian cells, including elongation, segregation and constriction of the peroxisomal membrane, and division. Pex11 is a Pex gene factor required for peroxisome biogenesis and was shown to promote peroxisome division in yeast and mammalian cells by promoting elongation (1, 4, 17, 25, 28) .
In mammals, three subtypes of the Pex11 gene (␣, ␤, and ␥) have been identified and mapped onto different chromosomes. Whereas Pex11␣ and Pex11␥ are tissue specific and expressed most prominently in the liver, Pex11␤ is expressed ubiquitously (20, 28) . Mice lacking Pex11␤ display many of the pathological characteristics of Zellweger syndrome mouse, including neonatal lethality (21) . In contrast, Pex11␣ knockout (Pex11␣ Ϫ/Ϫ ) mice are viable, showing no obvious defect in constitutive peroxisome division (20) . However, in the present study, we showed that Pex11␣ is important for the growth and division machinery of peroxisomes and that Pex11␣ deficiency affects peroxisome elongation and abundance, which affects peroxisomal fatty acid oxidation and contributes to increased lipid accumulation in the liver.
MATERIALS AND METHODS

Generation of Pex11␣
Ϫ/Ϫ mice. A 13.4-kb DNA fragment used to construct the targeting vector was first subcloned from the murine C57BL/6 genomic library and further subcloned into a 2.4-kb backbone vector. The region was designed such that the short homology arm extended 2.4 kb to the 5= side of loxP/FRT Neo cassette. The long homology arm starts at the 3= side of the loxP/FRT Neo cassette and is 7.9 kb long. The loxP/FRT Neo cassette replaced 3.1 kb of the gene, which included exons 1 and 2. The deduced genomic structure of the Pex11␣ gene is shown in Fig. 1A . The targeting vector was linearized using Notl and transfected by eletroporation of iTL IC1 C57BL/6 embryonic stem cells. After selection with the antibiotic G418, surviving clones were expanded for PCR analysis to identify recombinant ES clones with A1/N1 primers (A1, 5=-TGTCCCATCTGCAG-CAAGATCTC-3=; primer N1, 5=-TGCGAGGCCAGAGGCCACTT-GTGTAGC-3=). Positive clones were expanded again, and three independently derived Pex11␣ ϩ/Ϫ ES clones were injected into C57BL/6 blastocysts to generate male chimeras, which were intercrossed with C57BL/6 mice. Heterozygous F1 mice were either intercrossed to produce homozygous Pex11␣ Ϫ/Ϫ mice or backcrossed with C57BL/6 mice five times prior to Pex11␣ Ϫ/Ϫ mice being generated. Pex11␣ mRNA and protein levels of F2 generation mice and beyond, which were fed normal chow supplemented with 0.2% fenofibrate [PPAR␣ agonist (wt/wt); Wako, Osaka, Japan] for 2 wk, were determined using real-time RT-PCR and immunoblotting, respectively.
Diet. Mice were housed in a temperature-controlled room on a 12:12-h dark-light cycle. All experimental protocols involving mice were approved by the Ethical Review Board of National Cerebral and Cardiovascular Center (Japan) and performed according to the guidelines for the care and use of experimental animals of the National Cerebral and Cardiovascular Center and the National Institutes of Health's Guide for the Care and Use of Laboratory Animals. Experiments were conducted such that pain and discomfort to the mice were minimized. Mice were allowed ad libitum access to food and water. A normal diet consisting of 24.9% protein, 4.6% fat (calorie ratio 12%), and 51.4% carbohydrate (wt/wt) was compared with a high-fat diet (HFD) consisting of 23% protein, 35% fat (calorie ratio 62.2%), and 25.3% carbohydrate. Under fasting conditions, wild-type (WT) mice and Pex11␣ Ϫ/Ϫ mice were deprived of food but provided water ad libitum for 12, 24, or 48 h starting at the beginning of the light cycle (7 AM). Normal chow supplemented with 0.015% fenofibrate (wt/wt) was given to WT mice and Pex11␣ Ϫ/Ϫ mice for 2 days before electron microscopy, immunofluorescence microscopy, and immunoblot analysis. To observe the phenotype of Pex11␣ Ϫ/Ϫ mice, body weights of 5-wk-old male Pex11␣ Ϫ/Ϫ mice and age-matched WT mice were measured weekly.
Metabolite assays. WT and Pex11␣ Ϫ/Ϫ mice were subsequently euthanized under pentobarbital sodium anesthesia. Blood was collected from the abdominal vein and centrifuged for 10 min to collect serum. Serum was kept at Ϫ80°C. The liver was removed and kept at Ϫ80°C. Total lipids were extracted from ϳ100 mg of liver, as described previously (8) . Triglyceride (TG) content was measured using a TG kit (Sekisui Medical, Tokyo, Japan). Serum free fatty acids (FFAs), ␤-hydroxybutyrate, and TGs were measured using commercial kits (Biovision, Milpitas, CA). Very low-density lipoprotein (VLDL) production is one of main fates of fatty acid metabolism in hepatocytes. We performed a VLDL production test to assess the hepatic capacity of VLDL secretion. After a 16-h fast, mice were injected intravenously with 500 mg/kg of tyloxapol (a lipoprotein lipase inhibitor; Sigma, St. Louis, MO) after a blood sample was taken from the neck vein under gas anesthesia (isoflurane). Plasma TGs were subsequently measured at 1, 2, and 4 h after injection (2) . To observe whether Pex11␣ deficiency affects gluconeogenesis, we measured blood glucose concentration during fasting. Blood was taken from the tail vein at the end of the dark cycle when the mice were in a fully fed state. Food was subsequently withdrawn, and blood glucose was measured at several time points by using a blood glucose monitoring system (Nipro, Osaka, Japan) according to the manufacturer's instructions.
Intraperitoneal glucose tolerance test. WT and Pex11␣ Ϫ/Ϫ mice were fasted for 12 h and provided water ad libitum. After measuring fasting glucose levels, mice were injected intraperitoneally with 1.5 g/kg glucose. Next, blood glucose levels were measured at 30, 60, 90, 120, and 180 min after injection. Blood glucose was measured as described in the metabolite assays.
Oil Red O staining. Liver tissue was fixed in 10% formalin. Livers were washed using phosphate-buffered saline (PBS), embedded in optimal cutting temperature compound, and sectioned at 7 m. The sections were then washed twice with ddH 2O and once with 60% isopropanol. Dried plates were incubated for 10 min in Oil Red O working solution. Sections were immediately destained by washing three times with ddH 2O and photographed.
Gene expression analysis. RNA was extracted from livers using Trizol reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. cDNA obtained by reverse transcription was amplified using the appropriate primers, and mRNA expression levels were determined by real-time RT-PCR using a commercial kit (Applied Biosystems, Foster City, CA). All samples were analyzed in triplicate multiplex reactions, which measured both the gene of interest and GAPDH as an internal control, as described previously (15) .
Immunofluorescence microscopy and peroxisome abundance. Liver tissue was fixed in Bouin's fixative solution (Bioscience, Allentown, PA) overnight at 4°C and then placed in 70% alcohol. Livers were washed using PBS, embedded in optimal cutting temperature compound, and then sectioned at 7 m. Sections were then washed twice in PBS and permeabilized for 10 min in PBS containing 0.5% Triton X-100. The sections were again washed twice with PBS and then incubated with blocking buffer (2% bovine serum albumin, 0.5% Triton X-100 in PBS) for 60 min, followed by incubation with either rabbit anti-PMP70 (Invitrogen) or goat anti-catalase (Santa Cruz Biotechnology, Santa Cruz, CA) primary antibodies overnight at 4°C. Sections were then washed five times with PBS containing 0.5% Triton X-100 and incubated with Texas Red-conjugated donkey anti-goat secondary antibodies (Abcam Cambridge, UK) or Alexa Fluor 488-conjugated goat anti-rabbit secondary antibodies (Invitrogen) for 60 min at room temperature. Sections were washed five times with PBS and mounted on glass slides. To determine the number of peroxisomes in liver sections, fluorescence images were acquired using a confocal laser-scanning microscope (Olympus, Tokyo, Japan) and analyzed using Image J software (National Institutes of Health, Bethesda, MD). At least 20 randomly selected independent fields were photographed. Peroxisomes were counted using the Particle Analysis package of Image J. The ratio of empty peroxisomes was calculated as follows: (detectable peroxisomes stained with PMP70 Ϫ detectable peroxisomes stained with catalase)/detectable peroxisomes stained with PMP70.
Peroxisome enrichment and immunoblot analysis. For peroxisome catalase and PMP70 immunoblotting, density gradient centrifugation was performed to enrich peroxisomes from the liver, as described previously (10) , by using a peroxisome enrichment kit (Thermo Scientific, Waltham, MA) according to the manufacturer's instructions. Isolated peroxisomes were dissolved in buffer A [50 mM Tris·HCl, pH 8.0, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, and 0.1% SDS containing complete protease inhibitor cocktail (Calbiochem, Darmstadt, Germany)]. After centrifugation at 15,000 g for 10 min at 4°C, the supernatant was collected and kept at Ϫ80°C. Immunoblotting was performed using antibodies against catalase (Santa Cruz Biotechnology) and PMP70 (Invitrogen). For Pex11␣ immunoblotting, 100 mg of the liver was homogenized in buffer A. Samples were centrifuged at 15,000 g for 10 min at 4°C, and the supernatant was collected and kept at Ϫ80°C. Immunoblotting was performed using antibodies against Pex11␣ and ␤-actin (Santa Cruz Biotechnology).
Immunoelectron microscopy. Mice were euthanized under pentobarbital sodium anesthesia. The livers were removed, cut into 1-m sections, and fixed with 4% paraformaldehyde and 0.05% glutaraldehyde in 0.1 M phosphate buffer (PB), pH 7.4, at 4°C for 1 h and then rinsed three times with 0.1 M PB for 15 min. The dehydrated samples were embedded in resin and polymerized at 50°C overnight. Thin sections (80 nm) were incubated with rabbit anti-PMP70 antibodies (Invitrogen) and visualized using gold particles (Anti Rabbit IgG; British BioCell International, Cardiff, UK). Sections were stained using 2% uranyl acetate, secondary-stained using lead stain solution (Sigma-Aldrich), and then analyzed using a transmission electron microscope (JEM-1200EX; JEOL, Tokyo, Japan). To quantitatively evaluate peroxisome morphology, 40 -50 fields per coverslip were examined, and roundness and area were measured using the Measure Analysis package of Image J based on the following equation: roundness ϭ perimeter 2 /(4 ϫ ϫ area). Roundness was categorized according to the following parameters and is presented in Quantification and statistical analysis. Statistical analysis of peroxisome roundness and area was conducted using the Wilcoxon/KruskalWallis test; other data were analyzed using one-way analysis of variance and Student's t-test followed by Bonferroni Correction using the JMP statistical analysis package (SAS Institute, Cary, NC). P Ͻ 0.05 was considered significant. Data are presented as means Ϯ SD.
RESULTS
Generation of Pex11␣
Ϫ/Ϫ mice. We generated a targeting vector that replaced exons 1 and 2 (including the ATG start codon in exon 1) of the Pex11␣ gene (Fig. 1A) . After gene targeting and germline transmission, we bred mice that were homozygous for the targeted allele. Pex11␣ Ϫ/Ϫ mice lacked detectable Pex11␣ mRNA and protein even after treatment with 0.2% fenofibrate for 2 wk, as determined using real-time RT-PCR and immunoblotting, respectively (Fig. 1, B-D) . Pex11␣ Ϫ/Ϫ mice are obese and have fatty livers. The body weights of Pex11␣ Ϫ/Ϫ mice were significantly higher than those of WT mice under a normal diet ( Fig. 2A) . Furthermore, Pex11␣ Ϫ/Ϫ mice ages 5-17 wk were fed a normal diet (n ϭ 10 mice/group). Body weight was measured weekly. B: WT and Pex11␣ Ϫ/Ϫ mice were fed a high-fat diet (HFD) for 12 wk (n ϭ 8 mice/group). *P Ͻ 0.05; **P Ͻ 0.01. mice had fatty livers beginning at 30 wk of age. Following Oil Red O staining of liver sections, numerous small lipid droplets were observed in 30-wk-old Pex11␣ Ϫ/Ϫ mice but not in agematched WT mice (Fig. 3A, left) . This result was confirmed by hepatic biochemical experiments. Hepatic TG concentrations in Pex11␣ Ϫ/Ϫ mice were significantly higher than those in WT mice (Fig. 3B) . However, serum TG concentrations did not differ significantly between Pex11␣ Ϫ/Ϫ mice and WT mice (Fig. 3C ).
Pex11␣
Ϫ/Ϫ mice response to HFD and fasting. Under an HFD, the body weights of Pex11␣ Ϫ/Ϫ mice were significantly higher than those of WT mice (Fig. 2B ). Feeding of a HFD for 12 wk resulted in lipid accumulation in the livers of Pex11␣ Ϫ/Ϫ mice and WT mice (Fig. 3A, middle) . Furthermore, hepatic TG concentrations in Pex11␣ Ϫ/Ϫ mice were significantly higher than those in WT mice (Fig. 3B) . We also characterized the response to fasting. Numerous lipid droplets were observed in fasting Pex11␣ Ϫ/Ϫ mice, but few droplets were observed in fasted WT mice (Fig. 3A,  right) . Furthermore, hepatic TG concentrations in fasted Pex11␣ Ϫ/Ϫ mice were significantly higher than those in fasted WT mice (Fig. 3B) . Ϫ/Ϫ mice (n ϭ 6 -8 mice/group). D: very low-density lipoprotein production in mice fasted for 16 h and injected intravenously with 500 mg/kg of tyloxapol (a lipoprotein lipase inhibitor). Plasma TG was measured (%change from baseline is shown; n ϭ 6 mice/group). *P Ͻ 0.05; **P Ͻ 0.01.
Diminished hepatic ketogenesis and VLDL secretion in Pex11␣
Ϫ/Ϫ mice. Serum FFA levels were not elevated but were similar between WT mice and Pex11␣ Ϫ/Ϫ mice after 12 h of fasting; these levels were significantly elevated compared with those of fed mice after 24 h of fasting and significantly higher in Pex11␣ Ϫ/Ϫ mice compared with WT mice (Fig. 4A) . Serum ␤-hydroxybutyrate levels were significantly elevated in WT mice but not in Pex11␣ Ϫ/Ϫ mice after 12 h of fasting, and these levels were significantly elevated in WT and Pex11␣ Ϫ/Ϫ mice after 24 h of fasting. Serum ␤-hydroxybutyrate levels in Pex11␣ Ϫ/Ϫ mice were significantly lower after 12 h of fasting but similar to those in WT mice under other conditions (Fig. 4B) . Tyloxapol administration to WT and Pex11␣ Ϫ/Ϫ mice resulted in a steady increase of plasma TGs after injection. Plasma TG levels increased at lower rates in Pex11␣ Ϫ/Ϫ mice than in WT mice (Fig. 3D ). Blood glucose levels in Pex11␣ Ϫ/Ϫ mice were similar to those in WT mice during fasting (Fig. 4C) . Furthermore, glucose tolerance tests showed similar levels of blood glucose in WT mice and Pex11␣ Ϫ/Ϫ mice (Fig. 4D ).
Number and size of peroxisomes are decreased in Pex11␣
Ϫ/Ϫ mice. Based on both catalase and PMP70 staining, the number of peroxisomes in the livers of Pex11␣ Ϫ/Ϫ mice was found to be significantly lower than that in the livers of WT mice (Fig. 5, A and C) . Although there was no statistically significant difference in peroxisomal size between Pex11␣ Ϫ/Ϫ mice and WT mice, we did observe a tendency toward the occurrence of smaller peroxisomes in the absence of Pex11␣ (Fig.  5E ). To verify this characterization, we used immunoelectron microscopy to assess peroxisome size (Fig. 6A) Fig. 6F ).
Number of effective peroxisomes is decreased in Pex11␣
Ϫ/Ϫ mice. Fenofibrate induced Pex11␣ but not Pex11␤ expression after treatment for 2 days (Fig. 5F ). We examined peroxisome morphology after fenofibrate treatment using a confocal laserscanning microscope and found that there was a larger number of peroxisomes in WT mice and that the peroxisomes were distally elongated (arrows in Fig. 6B ). Ultrastructural analysis also revealed more tubular and elongated peroxisomes (arrows in Fig. 6A ) in the livers of WT mice. Statistical analysis showed that irregular spheromes (roundness Ն1.15, i.e., categories VI-X) were more prevalent in WT mice than in Pex11␣ Ϫ/Ϫ mice fed either normal chow (40 vs. 23.7%, P Ͻ 0.0001, Wilcoxon/Kruskal-Wallis test; Fig. 6C ) or normal chow supplemented with fenofibrate (37.3 vs. 11.6%, P Ͻ 0.0001, Wilcoxon/Kruskal-Wallis test; Fig. 6D ) for 2 days. Newly formed peroxisomes from the ER, which contains only PMP70 but not catalase, increased in WT mice and Pex11␣ Ϫ/Ϫ mice after treatment with fenofibrate, particularly in Pex11␣ Ϫ/Ϫ mice (Fig. 5, A and B) . Furthermore, significantly higher ratios of empty peroxisomes containing only PMP70 but not catalase were observed in Pex11␣ Ϫ/Ϫ mice compared with WT mice fed either a normal diet or a diet supplemented with fenofibrate for 2 days (P Ͻ 0.01, Student's t-test; Fig. 5D ). In agreement with these results, immunoblotting showed a significantly lower ratio of catalase and PMP70 proteins in the peroxisomes of Pex11␣ Ϫ/Ϫ mice after fenofibrate treatment for 2 days (Fig. 7) . (ACSL1), ATP-binding cassette, subfamily D, member 2 (ABCD2), acyl-coenzyme A oxidase 1 (ACOX1), acetyl-coenzyme A acyltransferase 1A (ACAA1A), and acyl-CoA thioesterase 3 (ACOT3)] was induced by fasting. Under fed conditions, ABCD2 and ACOT3 mRNA levels were significantly higher in WT mice than in Pex11␣ Ϫ/Ϫ mice by approximately eight-and 60-fold, respectively; however, similar levels of ACSL1, ACOX1, and ACAA1A were observed between WT mice and Pex11␣ Ϫ/Ϫ mice (Fig. 8) . In contrast, under fasting conditions, ACSL1, ACOX1, and ACAA1A expression levels were significantly higher in Pex11␣ Ϫ/Ϫ mice than in WT mice (Fig. 8) . Other genes involved in fatty acid oxidation [PPAR␣, cytochrome P450, family 4, subfamily a, polypeptide 10 (CYP4A10), and hydroxyl methylglutaryl-CoA synthase 2 (HMGCS2)] and Pex11␣ expression were also induced by fasting, and PPAR␣, CYP4A10, and HMGCS2 expression were significantly higher in Pex11␣ Ϫ/Ϫ mice than in WT mice under fasting conditions (Fig. 8) .
DISCUSSION
Our results demonstrate that Pex11␣ deficiency is involved in lipid accumulation and contributes to fatty liver. Pex11␣ Ϫ/Ϫ mice had impaired hepatic peroxisomal fatty acid oxidation, resulting in a phenotype characterized by elevated FFA levels, obesity, and a fatty liver, which are similar to the phenotype of PPAR␣ (a gene upstream of Pex11␣)-deficient mice (16) . However, hypoglycemia was not observed in Pex11␣ Ϫ/Ϫ mice. In contrast, we observed slight hypoketonemia in Pex11␣ Ϫ/Ϫ mice after 12 h of fasting but not after 24 h of fasting. PPAR␣ is the nuclear receptor primarily responsible for lipid oxidation and ketogenesis in the liver, particularly in response to systemic signals during starvation (16, 19) . Furthermore, a key step in generating ketone bodies is mediated by the mitochondrial form of HMGCS2, a known target of PPAR␣ (5, 26) . Higher levels of PPAR␣ and HMGCS2 in Pex11␣ Ϫ/Ϫ mice after 24 h of fasting may trigger compensatory formation of ketone bodies to diminish the differences induced by Pex11␣ deficiency after 12 h of fasting. These results indicate that Pex11␣ deficiency impairs ketogenesis during short periods of starvation (12 h), but compensatory formation of ketone bodies occurs during longer periods of starvation (24 h) via the PPAR␣ signaling system. In the present study, a significant increase in lipid accumulation in the liver may have resulted from decreased VLDL secretion and peroxisomal fatty acid oxidation. VLDL production is one of main fates of fatty acid metabolism in hepatocytes. Decreased VLDL secretion from liver may lead to accumulation of TGs in the livers of Pex11␣ Ϫ/Ϫ mice. Recent studies have shown that Pex11␣ and Pex11␤ may act in different peroxisome proliferation pathways (17, 22) . Pex11␤ was shown to promote peroxisome elongation and Ϫ/Ϫ and WT mice. The ratio of empty peroxisomes was calculated as follows: (detectable peroxisomes stained with PMP70 Ϫ detectable peroxisomes stained with catalase)/detectable peroxisomes stained with PMP70. F: Pex11␣ and Pex11␤ mRNA levels were measured using real-time RT-PCR in livers from WT and Pex11␣ Ϫ/Ϫ mice fed normal chow supplemented with 0.015% fenofibrate for 2 days (n ϭ 6 -8 mice/group). *P Ͻ 0.05; **P Ͻ 0.01.
division (28) . Furthermore, previous studies have shown that peroxisomes in mammalian cells often exhibit a tubular morphology (27, 36) . Our data indicate that Pex11␣ deficiency impairs peroxisome elongation and hinders peroxisome division; this may result in smaller and a lower number of peroxisomes with a regular spherical shape present in the livers of Pex11␣ Ϫ/Ϫ mice. We propose that this small size and regular spherical shape signifies a lower exposed cellular surface area, which may reduce the efficiency of fatty acid translocation from the cytoplasm into the peroxisomes, thereby impairing peroxisomal fatty acid metabolism.
Peroxisomes can also form de novo from the ER via a maturation process (12, 13, (31) (32) (33) . Hoepfner et al. (13) proposed that during de novo formation, preperoxisomal vesicles bud from the ER membrane and fuse homotypically, followed by the formation of large preperoxisomal structures that acquire additional PMPs to form import machinery. Only when the import machinery for lumenal proteins is incorporated into the newly forming peroxisome structure can the lumenal protein actually be imported, completing the maturation process to form functional peroxisomes (30, 31) . These possibilities led us to hypothesize that newly forming peroxisomes from the ER are ineffective (at least early in the process) and that there is a larger number of ineffective newly forming peroxisomes in Pex11␣ Ϫ/Ϫ mice. Our results support this hypothesis and indicate that newly formed peroxisomes in Pex11␣ Ϫ/Ϫ mice lack metabolic function.
ABCD2 encodes the adrenoleukodystrophy-related protein, a peroxisomal member of the ATP-binding cassette halftransporters, which are known to participate in the entry of fatty acids into peroxisomes (9) . ACOT3 encodes a peroxisomal longchain acyl-CoA thioesterase that catalyzes the hydrolysis of acylCoAs to free fatty acid and coenzyme A (CoASH) to prevent CoASH sequestration and to facilitate excretion of chainshortened carboxylic acids from the peroxisomes to mitochondria for further metabolism (14) . Decreased ABCD2 and ACOT3 expression in Pex11␣ Ϫ/Ϫ mice may result in an impaired capacity for peroxisomal fatty acid ␤-oxidation particularly of VLCFA and long-chain fatty acids (9) . Under fasting conditions, higher expression levels of PPAR␣ and its target genes (ACOX1, ACLS1, ACAA1A, CYP4A10, and HMGCS2) in the livers of Pex11␣ Ϫ/Ϫ mice may have resulted because impaired peroxisomal fatty acid oxidation leads to the accumulation of fatty acid oxidation intermediates that subsequently activate PPAR␣ and its target genes. Although activated PPAR␣ can induce its target gene Pex11␣ and promote peroxisome multiplication, as described above, peroxisome multiplication may depend on forming new peroxisomes from the ER in Pex11␣ Ϫ/Ϫ mice, but these new peroxisomes may lack metabolic function. As a result, higher ACLS1, ACOX1, and ACAA1A expression induced by PPAR␣ in Pex11␣ Ϫ/Ϫ mice may be ineffective for recovering metabolic functions. Whether and how Pex11␣ deficiency affects peroxisomal fatty acid oxidationrelated protein import and activity and how it subsequently affects peroxisome metabolic function requires further study.
Consistent with our results, Pex11␣ overproduction is sufficient for inducing peroxisome proliferation in mouse and human cultured cells (23) . However, in contrast to our results, Li et al. (20) reported that mice lacking Pex11␣ developed normally, showing no obvious defects in peroxisome abundance and metabolism. The reason for this difference is presently unclear. However, in the present study, HFD and fasting conditions, which were not investigated by Li et al. (20) , were investigated. Pex11␣ is an inducible gene, and phenotypic differences in WT mice and Pex11␣ Ϫ/Ϫ mice will be more evident under HFD and fasting conditions, in which the Pex11␣ gene is upregulated. This may account for the differences between the study of Li et al. (20) and our results.
In conclusion, our results demonstrate that Pex11␣ deficiency impairs peroxisome elongation and abundance and peroxisomal fatty acid oxidation, contributing to increased lipid accumulation in the livers of Pex11␣ Ϫ/Ϫ mice. mice. Peroxisomes were enriched from the livers of WT and Pex11␣ Ϫ/Ϫ mice fed normal chow supplemented without or with 0.015% (wt/wt) fenofibrate (control and fibrate, respectively) for 2 days. Total protein was extracted from isolated peroxisomes using buffer A. Immunoblotting analysis was used to determine the ratio of peroxisomal matrix protein catalase and peroxisomal integral membrane protein PMP70 (n ϭ 4 -6 mice/group). *P Ͻ 0.05. , and hydroxyl methylglutaryl-CoA synthase 2 (HMGCS2) mRNA levels were measured using real-time RT-PCR in the livers of WT and Pex11␣ Ϫ/Ϫ mice fed ad libitum or after a 24-h fasting. GAPDH was used as an internal control (n ϭ 8 -10 mice/group). *P Ͻ 0.05; **P Ͻ 0.01.
